MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/hep.0000000000001249

Медицинская библиотека · Hepatology (Baltimore, Md.) · 2025

Discovery of a MET -driven monogenic cause of steatotic liver disease.

Pinto E Vairo Filippo, Zimmermann Michael T, Wagenknecht Jessica, Jorge Salomão Doria, Tian Shulan, Vierkant Robert A, Luehrs Anthony C, Milech de Assunção Thiago, Mathison Angela, Atwal Paldeep S, Cao Yang, Allen Alina M, Klee Eric W, Urrutia Raul, Lazaridis Konstantinos N

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND AND AIMS: Metabolic dysfunction-associated steatotic liver disease affects about a third of adults worldwide and is projected soon to be the leading cause of liver cirrhosis. It occurs when fat accumulates in hepatocytes and can progress to metabolic dysfunction-associated steatohepatitis, liver cirrhosis, and HCC. Metabolic dysfunction-associated steatotic liver disease pathogenesis is believed to involve a combination of genetic and environmental risk factors. Single nucleotide polymorphisms have been implicated, but non-syndromic monogenic causes are lacking.

APPROACH AND

RESULTS

We identified a novel genetic variant in a familial case of metabolic dysfunction-associated steatohepatitis and performed deep variant functional analysis, including protein modeling, dynamics, and cell-based assays to assess molecular mechanisms of dysfunction and altered cellular signaling. We analyzed exome sequencing data of 3904 individuals with steatotic liver disease (SLD) to identify additional cases and establish the link between specific gene variants and SLD diagnosis. We discovered and functionally validated the NM_000245.4:c.3505A>T; p.(Ile1169Phe) variant in the MET (mesenchymal-epithelial transition) kinase domain as a monogenic cause of SLD. Subsequently, we detected additional ultra-rare, previously uninterpreted, and likely deleterious variants in MET from screening sequencing data. Among individuals with confirmed SLD based on electronic record review, 1.1% (45/3904) had rare predicted deleterious MET variants. Eight of 45 (17.7%) individuals had predicted deleterious variants in the MET kinase domain confirmed to be functionally like the familial case variant.

CONCLUSIONS

We report the first germline nonmalignant rare MET -driven disease, a monogenic form of SLD.

Для цитирования: Pinto E Vairo Filippo, Zimmermann Michael T, Wagenknecht Jessica, Jorge Salomão Doria, Tian Shulan, Vierkant Robert A, Luehrs Anthony C, Milech de Assunção Thiago, Mathison Angela, Atwal Paldeep S, Cao Yang, Allen Alina M, Klee Eric W, Urrutia Raul, Lazaridis Konstantinos N. Discovery of a MET -driven monogenic cause of steatotic liver disease.. Hepatology (Baltimore, Md.). 2025. DOI: 10.1097/hep.0000000000001249.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.